Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study - Wikidata - awgldk - TriplyDB

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

http://www.wikidata.org/entity/Q34897630

about

Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass--a cross sectional study.Total cholesterol and LDL levels decrease before rheumatoid arthritis.Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis.Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity.Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis Risk factors for coronary heart disease in connective tissue diseases Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis.High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study.Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis Metabolic syndrome in rheumatoid arthritis Atherogenic lipid profiles and its management in patients with rheumatoid arthritis.The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs.Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study.Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics.Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Psoriasis comorbidities.Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study Serum lipid changes and insulin resistance in familial Mediterranean fever.Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study.Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis.The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate?The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis.Rheumatoid arthritis and cardiovascular disease

P2860

Q28552434-047E497B-624C-4CAD-936D-014AD11865DA Q33633643-44868FC0-DD31-41AB-B7B6-2B7A1393F6FB Q33793453-469B2CD3-8933-4843-9D0B-AC75A11C4E7A Q33931317-9AF95559-D6F0-47D2-AFD5-C764C0774924 Q34614038-AE79F33D-D886-4A77-9EB1-D391F5305D0D Q34684331-CE378F84-939F-446D-AA60-2FE611659287 Q35257568-EC0A5C3A-6D6E-40B7-A87C-02EB9C37DBD6 Q35308212-ECDDC794-22E8-4E92-ABC7-0921780188CB Q35681167-FE0A262B-4C4C-46E1-BC3D-EDC83632572F Q35769101-78796E48-7C49-42C6-8DC5-DF556FCD5F79 Q35891702-309E7014-3E09-488F-A4CB-3944B6ED50F3 Q36056947-CED5E849-23AA-4295-A941-D43CC3BA87BF Q36113215-F7BDBC59-0DA3-44EE-83F8-EF428B3D447E Q36204149-8FA8EA30-7F0E-49B0-99AE-0D7B269E9C35 Q36241707-CDC38E8A-6492-471A-A6D9-F4C3B3F8CDD5 Q36245981-BE60032F-7FB8-4B8E-B0DF-CEB0C032A9D8 Q36456346-CF96AD42-6D20-49A3-94F9-97B1EAE6E3B7 Q36568868-2153757D-6C56-477D-9EBA-4080FCF4D77B Q36596894-95059D89-3B3A-463E-B56E-276C531C7014 Q36745032-277922DC-041C-44F2-A1B6-FD93C9F4B2CC Q36757006-0758121C-2DB6-4C8D-AE72-7267CF1855C7 Q36757060-21E57235-2862-4C5C-A237-50EE467B2E11 Q36802963-F2299C03-83F0-4868-9D79-C6B8DC656B2E Q36812587-7FDC893A-74A3-4FBA-9DE8-A45C0DEBBB79 Q36951050-CF48654B-204F-4E2A-99A8-8E1C5D40EE74 Q36955395-560EB664-C849-4BC4-BDC5-C30C84AA47A1 Q37058791-562BBC23-4FA5-4308-9259-2FDBC6160E4B Q37084274-2D758216-0E49-47A7-B30A-65564FDB903A Q37129611-0537C971-9C74-45BA-8057-8B3B97A3F5F6 Q37206912-4E33417E-942E-4CCD-BB14-83BC220F8F63 Q37209902-783564D6-6802-4819-B0DC-4D684E5F593F Q37296397-98759A3E-DED5-4E71-929B-E57EE115D3F8 Q37430645-63F36F03-D5F1-4C91-B94A-A04571F7D0F7 Q37479238-4B82102A-01E6-4EDD-AE22-EFD1207A4BDD Q37588725-BF6A832B-D70A-4846-ABF6-36368BED072B Q37612713-CF969B6C-4E53-45E0-BE71-85742BEAF775 Q37640953-65A00656-AC28-4311-99CA-EE9ABBD8786F Q37651150-95F79303-7153-4993-BA5B-018660088326 Q37817050-A15E601B-410B-48F0-87F1-E2ECB33F2446 Q38149252-154CFF7A-C033-4E18-AFC5-D997E0BB3F83

P2860

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

http://www.wikidata.org/entity/Q34897630

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Atherogenic lipid profile is a ...... prospective, controlled study

@ast

Atherogenic lipid profile is a ...... prospective, controlled study

@en

Atherogenic lipid profile is a ...... prospective, controlled study

@nl

type

label

Atherogenic lipid profile is a ...... prospective, controlled study

@ast

Atherogenic lipid profile is a ...... prospective, controlled study

@en

Atherogenic lipid profile is a ...... prospective, controlled study

@nl

prefLabel

Atherogenic lipid profile is a ...... prospective, controlled study

@ast

Atherogenic lipid profile is a ...... prospective, controlled study

@en

Atherogenic lipid profile is a ...... prospective, controlled study

@nl

P1433

Q34897630-8353FE0E-2277-4B0F-8830-27C1475E771B

P1476

Q34897630-0D41D1E3-32D0-46BF-937B-A79AE11AAF63

P2093

Q34897630-33139CA5-3AE2-41CA-A39C-D5AE784FEED9

Q34897630-394A87BB-FD4C-43AE-AD9A-6864C1053822

Q34897630-90BE0FB9-3588-43BA-AACF-82CABB8FE3E3

Q34897630-9C2D1D61-67EA-460A-BC31-85CD8782D09D

Q34897630-9FD19B7A-A998-4D41-ABA8-EB3B0BDB6C4B

Q34897630-A4DA9658-7C83-4ED3-BFA3-53F60826F21C

Q34897630-B0DC43E0-5F69-4FCE-B9F0-57C7E0426E1D

P2860

Q34897630-06EDEBEC-D436-4051-A1CD-218766321D46

Q34897630-0B5F0D3F-D938-463F-9780-C3E156D07EC5

Q34897630-0E6A3F2F-C209-4C89-9F32-38BDE5651BC1

Q34897630-0F82C3C6-3B03-415B-AF7F-CA186B6B064A

Q34897630-1845E549-AD0C-4E4F-84F1-23294F456569

Q34897630-185EF640-1458-441D-97F1-9084EC60ED5A

Q34897630-202E0E10-14BC-49FF-B017-72123B032212

Q34897630-256B332F-96CF-4C60-A70E-BCFD357DC5D8

Q34897630-29C89AB3-5FE3-4633-A0AA-83EDC0C9EEBC

Q34897630-31AD0754-F8A6-41D8-BD53-E76019014447

P2888

Q34897630-E9B96F95-94D7-40FF-B127-A29C0701A452

P304

Q34897630-76AA11BB-11D5-4B32-B90D-C2550130AA5D

P31

Q34897630-5D7C7D01-9947-4C23-83A1-6E091D7F6743

P356

Q34897630-7BFA43B1-1D84-4E25-A971-727D1721B13F

P433

Q34897630-383478E2-C670-4771-A46F-1C7E3B15DECC

P478

Q34897630-E076B625-310A-4BF8-93D1-D12B0349E6AF

P577

Q34897630-599E2960-84A7-4C6C-B875-DD1AACDB63D9

P5875

Q34897630-6D695857-8EC3-4182-B713-EBFA4E726756

P6179

Q34897630-DCDBAF03-9D0B-41FB-93C0-4BB2CCA45C95

P698

Q34897630-9E222162-A13A-4E7A-8FB8-EFBD5A1D908F

P921

Q34897630-A353BB93-7C5D-40CF-A33E-5E6639BC8708

P932

Q34897630-62F08E8A-16E4-4C33-A4C5-F15D6BAAF8F2

P356

P1433

Arthritis Research and Therapy

P1476

Atherogenic lipid profile is a ...... prospective, controlled study

@en

P2093

Alexandros A Drosos

http://www.w3.org/2001/XMLSchema#string

Alexandros D Tselepis

http://www.w3.org/2001/XMLSchema#string

Athanasios N Georgiadis

http://www.w3.org/2001/XMLSchema#string

Christina Kostara

http://www.w3.org/2001/XMLSchema#string

Eleni C Papavasiliou

http://www.w3.org/2001/XMLSchema#string

Evangelia S Lourida

http://www.w3.org/2001/XMLSchema#string

Yannis Alamanos

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update

The pathogenesis of atherosclerosis: a perspective for the 1990s

Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Ten year mortality and causes of death in patients with rheumatoid arthritis.

Coronary artery disease and rheumatoid arthritis.

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

Plasma cholesteryl ester transfer protein.

P2888

P304

R82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR1952

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7134335

http://www.w3.org/2001/XMLSchema#string

P6179

1048962136

http://www.w3.org/2001/XMLSchema#string

P698

16646989

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

1526648

http://www.w3.org/2001/XMLSchema#string